Incomplete RFA can accelerate cell proliferation, migration, and stemness in residual tumors. ERK inhibitor combined with Sal could inhibit cancer cell proliferation, migration, and stemness to synergically inhibit the progression of residual tumor.
Wang et al. (Thu,) studied this question.